Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

Biomatz

Biomatz is a biotech company developing AI-driven microbiome therapeutics using cooperative multi-strain design.​
2022
2-10
Seoul, Seoul-t’ukpyolsi, South Korea
BiotechnologynologyLife SciencePharmaceuticalsPrecision Medicine

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

1.53M

Last Funding Amount

1.53M

Last Funding Date

28-06-2023

Startup Stage

Seed

Lead Investors

Korea Investment Partners, Daewoong Pharmaceutical, Korea Kolmar Co., Gyeongnam Venture Investment